Simplex Trading’s Trinity Biotech TRIB Stock Holding History
Bought
Maintained
Sold
Other funds holding TRIB
HAIM
WN
MAWA
IWA
BCM
Simplex Trading's TRIB Position: Q2 2026 in Review
Simplex Trading reduced its Trinity Biotech (TRIB) stake by 37% in Q2 2026, selling an estimated $130 and leaving 12 shares worth $137. The position accounts for ﹤0.01% of the portfolio, ranked #9081.
Simplex Trading first reported a position in TRIB in Q4 2014 and has held it in 19 quarters since. The position peaked at $28K in Q1 2021. 19 funds tracked by Wall St. Rank hold TRIB as of Q2 2026.
- Simplex Trading held 12 shares of Trinity Biotech worth $137 as of Q2 2026.
- Simplex Trading sold 7 Trinity Biotech shares in Q2 2026, an estimated $130.
- Trinity Biotech made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #9081 holding.
- Simplex Trading first reported a position in Trinity Biotech in Q4 2014 and has held it in 19 quarters since.
- Simplex Trading's Trinity Biotech position peaked at $28K in Q1 2021.
- 19 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.